D. E. Shaw & Co., Inc. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$38,075,000
+103.6%
194,567
+76.8%
0.04%
+69.6%
Q2 2020$18,703,000
+115.6%
110,070
+46.4%
0.02%
+64.3%
Q1 2020$8,676,000
+16.5%
75,200
+15.3%
0.01%
+75.0%
Q4 2019$7,450,000
-50.9%
65,200
-63.3%
0.01%
-57.9%
Q3 2019$15,172,000
+42.3%
177,656
+15.3%
0.02%
+46.2%
Q2 2019$10,664,000
+34.6%
154,081
+42.4%
0.01%
+30.0%
Q1 2019$7,923,000
+218.1%
108,183
+146.1%
0.01%
+233.3%
Q4 2018$2,491,000
-84.2%
43,965
-78.4%
0.00%
-84.2%
Q3 2018$15,722,000
+233.7%
203,859
+187.3%
0.02%
+216.7%
Q2 2018$4,711,000
-46.6%
70,957
-57.9%
0.01%
-50.0%
Q1 2018$8,822,000
+491.3%
168,554
+504.6%
0.01%
+500.0%
Q4 2017$1,492,000
-84.6%
27,879
-84.3%
0.00%
-86.7%
Q3 2017$9,659,000
-46.2%
177,519
-48.9%
0.02%
-50.0%
Q2 2017$17,959,000
+87.4%
347,094
+127.6%
0.03%
+76.5%
Q1 2017$9,585,000
+182.2%
152,484
+136.8%
0.02%
+183.3%
Q4 2016$3,397,000
-74.3%
64,381
-73.7%
0.01%
-73.9%
Q3 2016$13,236,000
+253.8%
245,073
+164.7%
0.02%
+228.6%
Q2 2016$3,741,000
-65.6%
92,569
-61.7%
0.01%
-56.2%
Q4 2015$10,861,000
+111.6%
242,005
+81.8%
0.02%
+100.0%
Q3 2015$5,133,000
+76.9%
133,117
+122.1%
0.01%
+100.0%
Q2 2015$2,901,000
+36.8%
59,932
-0.1%
0.00%
+33.3%
Q1 2015$2,120,000
+133.2%
59,980
+111.9%
0.00%
+200.0%
Q4 2014$909,000
+173.0%
28,306
+215.6%
0.00%
Q3 2014$333,000
-21.1%
8,968
-18.7%
0.00%
-100.0%
Q2 2014$422,000
-58.7%
11,031
-50.8%
0.00%0.0%
Q1 2014$1,021,000
-72.2%
22,400
-75.7%
0.00%
-80.0%
Q4 2013$3,676,000
-68.6%
92,137
-65.5%
0.01%
-73.7%
Q3 2013$11,694,000
-27.4%
266,816
-47.9%
0.02%
-36.7%
Q2 2013$16,113,000512,1830.03%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 57,170$10,013,0005.39%
Boxer Capital, LLC 400,000$70,056,0002.25%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 110,153$19,292,0001.10%
DCF Advisers, LLC 13,300$2,329,0000.96%
XTX MARKETS LLC 2,418$423,0000.87%
FAIRFIELD, BUSH & CO. 15,035$2,633,0000.77%
Parcion Private Wealth LLC 4,520$792,0000.10%
Gulf International Bank (UK) Ltd 26,091$4,569,0000.06%
Princeton Portfolio Strategies Group LLC 1,500$263,0000.05%
Redpoint Investment Management Pty Ltd 2,392$419,0000.04%
View complete list of SEATTLE GENETICS INC shareholders